收费全文 | 8386篇 |
免费 | 627篇 |
国内免费 | 36篇 |
耳鼻咽喉 | 78篇 |
儿科学 | 251篇 |
妇产科学 | 239篇 |
基础医学 | 1239篇 |
口腔科学 | 150篇 |
临床医学 | 889篇 |
内科学 | 1682篇 |
皮肤病学 | 207篇 |
神经病学 | 782篇 |
特种医学 | 274篇 |
外科学 | 748篇 |
综合类 | 99篇 |
一般理论 | 9篇 |
预防医学 | 973篇 |
眼科学 | 121篇 |
药学 | 698篇 |
中国医学 | 19篇 |
肿瘤学 | 591篇 |
2024年 | 14篇 |
2023年 | 85篇 |
2022年 | 159篇 |
2021年 | 313篇 |
2020年 | 191篇 |
2019年 | 264篇 |
2018年 | 292篇 |
2017年 | 189篇 |
2016年 | 241篇 |
2015年 | 265篇 |
2014年 | 334篇 |
2013年 | 432篇 |
2012年 | 698篇 |
2011年 | 700篇 |
2010年 | 405篇 |
2009年 | 311篇 |
2008年 | 545篇 |
2007年 | 524篇 |
2006年 | 515篇 |
2005年 | 454篇 |
2004年 | 381篇 |
2003年 | 368篇 |
2002年 | 331篇 |
2001年 | 42篇 |
2000年 | 49篇 |
1999年 | 54篇 |
1998年 | 64篇 |
1997年 | 55篇 |
1996年 | 38篇 |
1995年 | 40篇 |
1994年 | 32篇 |
1993年 | 29篇 |
1992年 | 32篇 |
1991年 | 39篇 |
1990年 | 28篇 |
1989年 | 23篇 |
1988年 | 21篇 |
1987年 | 29篇 |
1986年 | 34篇 |
1985年 | 45篇 |
1984年 | 22篇 |
1983年 | 27篇 |
1982年 | 27篇 |
1981年 | 26篇 |
1980年 | 29篇 |
1979年 | 25篇 |
1977年 | 15篇 |
1974年 | 15篇 |
1973年 | 30篇 |
1928年 | 14篇 |
AIM:
to evaluate the clinical applicability of outcomes, according to the Nursing Outcomes Classification (NOC) in the evolution of orthopedic patients with Impaired Physical MobilityMETHOD:
longitudinal study conducted in 2012 in a university hospital, with 21 patients undergoing Total Hip Arthroplasty, evaluated daily by pairs of trained data collectors. Data were collected using an instrument containing five Nursing Outcomes, 16 clinical indicators and a five point Likert scale, and statistically analyzed.RESULTS:
The outcomes Body Positioning: self-initiated, Mobility, Knowledge: prescribed activity, and Fall Prevention Behavior presented significant increases in mean scores when comparing the first and final evaluations (p<0.001) and (p=0.035).CONCLUSION:
the use of the NOC outcomes makes it possible to demonstrate the clinical progression of orthopedic patients with Impaired Physical Mobility, as well as its applicability in this context. 相似文献Introduction
The aim of the study was to investigate the role of the proteolytic fraction from Vasconcellea cundinamarcensis, designated as P1G10, on the healing of chronic foot ulcers in neuropathic patients with diabetes 2.Methods
Fifty patients were enrolled in a prospective, randomized, double-blind trial, to verify the efficacy and safety of a topical dressing formulated with 0.1% P1G10, intended for wound healing, versus a hydrogel (control) protocol. Upon completion of the intervention, the outcome evaluated the number of patients attaining full epithelization (100%), or at least 80% healing. Statistical analysis compared the data on each group for the significance of the differences.Results
Collection of data was finished in week 16, and the results were analyzed by intention to treat. The results showed that, in the control group, 5 patients attained 100% ulcer healing, 3 patients?≥?80% healing and 11 experienced ulcer changes?≤?80%, and the remainder showed no changes or their wounds became worse. Meanwhile, in the P1G10 group, 11 patients experienced full healing, 4 had healing?≥?80% and 5 had ulcer changes?≤?lower than 80%, and the remainder showed no changes or their wounds became worse. The healing incidence for the first endpoint (100% healing) showed that the P1G10 group was 2.95-fold more efficacious than the control group (CI 95%) and 2.52-fold (CI, 95%) higher than its control for the second endpoint (80% healing).Conclusions
These data support the hypothesis that topical application of the proteolytic fraction identified as P1G10 significantly enhances foot ulcer healing compared to hydrogel treatment.The objective of our study was to systematically review the evidence about synchronous colorectal cancer diagnosed with or without computed tomography colonography (CTC).
Materials and methodsTwo systematic searches were performed (PubMed and EMBASE) for studies reporting the prevalence of synchronous colorectal cancer (CRC): one considering patients who underwent CTC and the another one considering patients who did not undergo CTC. A three-level analysis was performed to determine the prevalence of patients with synchronous CRC in both groups of studies. Heterogeneity was explored for multiple variables. Pooled prevalence and 95% confidence interval (CI) were calculated. A quality assessment (STROBE) was done for the studies.
ResultsFor CTC studies, among 2645 articles initially found, 21 including 1673 patients, published from 1997 to 2018, met the inclusion criteria. For non-CTC studies, among 6192 articles initially found, 27 including 111,873 patients published from 1974 to 2015 met the inclusion criteria. The pooled synchronous CRC prevalence was 5.7% (95% CI 4.7%–7.1%) for CTC studies, and 3.9% (95% CI 3.3%–4.4%) for non-CTC studies, with a significant difference (p = 0.004). A low heterogeneity was found for the CTC group (I2 = 10.3%), whereas a high heterogeneity was found in the non-CTC group of studies (I2 = 93.5%), and no significant explanatory variables were found. Of the 22 STROBE items, a mean of 18 (82%) was fulfilled by CTC studies, and a mean of 16 (73%) by non-CTC studies.
ConclusionsThe prevalence of synchronous CRC was about 4–6%. The introduction of CTC is associated with a significant increase of the prevalence of synchronous CRCs.
相似文献